Insights and News Curated for Life Science Experts by Life Science Experts....

INSIGHTS HUB

As Life Sciences recruiting becomes more selective and AI has continued advancement, incorporating these technologies into recruitment...

In a landmark decision, the Federal Trade Commission (FTC) has voted 3-2 to approve the issuance of a final rule that could reshape the...

How automation has corrupted candidate attraction, and what can you as a Hiring Manger or Talent Acquisition Professional do to be more...

Denmark, March 13, 2024 (GlobeNewswire) -- The Board of Directors of ChemoMetec appoints current COO Martin Helbo Behrens as new CEO. ...

Boston, MA, March 13, 2024 (PR Newswire) -- IFM Therapeutics, a leading biopharmaceutical firm specializing in innovative therapies for...

North Chicago, IL, February 20, 2024 (PRNewswire) -- AbbVie (NYSE: ABBV) announced that Robert A. Michael, the current president and...

Fremont, CA, February 26, 2024 (PRNewswire) -- Alamar Biosciences, a company specializing in precision proteomics for early disease...

Marietta, GA, February 13, 2024 (PRNewswire) -- BRIJ Medical announces Tim Gleeson as CEO and Joe Andrew as Senior VP of sales. Tim...

North Chicago, IL, and Nantes, France, February 28, 2024 (PRNewswire) -- AbbVie and OSE Immunotherapeutics announced a partnership to...

Minneapolis, MN, February 28, 2024 (Reuters) -- Agiliti Inc. (NYSE:AGTI), a provider of medical technology management and service...

Houston, February 5, 2024 (PRNewswire) -- Procyrion™, Inc., focused on enhancing patient outcomes in cardiac and renal care, has...

Wilmington, NC, February 14, 2024 (PRNewswire) -- Catalyst Clinical Research appointed Nik Morton as its CEO. Stepping into the role...

Thousands Oaks, CA, February 14, 2024 (PRNewswire) -- Latigo Biotherapeutics has announced that it has completed a $135 million series...

Marietta, GA, February 13, 2024 (PRNewswire) -- BRIJ Medical appointed Tim Gleeson as their new CEO. Tim brings a wealth of medical...

Foster City, CA, February 12, 2024 (Yahoo Finance) -- Gilead Sciences announces acquisition of CymaBay Therapeutics in a $4.3 billion...